Drug-Eluting Stent Restenosis
Author:
Affiliation:
1. From the Department of Medicine, Scripps Clinic, La Jolla, Calif.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Link
https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.110.962423
Reference19 articles.
1. The First Patient to Undergo Coronary Angioplasty — 23-Year Follow-up
2. Mehilli J Byrne RA Tiroch K Pinieck S Schulz S Kufner S Massberg S Laugwitz KL Schömig A Kastrati A; for the ISAR-DESIRE 2 Investigators. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) Study. J Am Coll Cardiol . March 5 2010. DOI:10.1016/j.jacc.2010.02.009. Available at: http://dx.doi.org/10.1016/j.jacc.2010.02.009. Accessed June 5 2010.
3. Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
4. Five-Year Follow-Up After Sirolimus-Eluting Stent Implantation
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. POSS and SSQ Materials in Dental Applications: Recent Advances and Future Outlooks;International Journal of Molecular Sciences;2023-02-24
2. Recent Advances in Polyurethane/POSS Hybrids for Biomedical Applications;Molecules;2021-12-22
3. NF2 deficiency accelerates neointima hyperplasia following vascular injury via promoting YAP-TEAD1 interaction in vascular smooth muscle cells;Aging;2020-05-18
4. Wild-type p53-induced phosphatase 1 promotes vascular smooth muscle cell proliferation and neointima hyperplasia after vascular injury via p-adenosine 5′-monophosphate-activated protein kinase/mammalian target of rapamycin complex 1 pathway;Journal of Hypertension;2019-11
5. Bio-Based Covered Stents: The Potential of Biologically Derived Membranes;Tissue Engineering Part B: Reviews;2019-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3